Get the Stockscreener App
4.76
4.80%
-0.24
After Hours:
4.76
Anavex Life Sciences Corporation Stock (AVXL) Forecast
The Anavex Life Sciences Corporation (AVXL) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $17.77, representing a +273.31% increase from the current price of $4.76. The highest analyst price target is $29.34, and the lowest is $6.1992.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month AVXL Price Target
Average 19.17
(+302.81% Upside)
Is Anavex Life Sciences Corporation (AVXL) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 59.47 | Neutral |
| STOCH(9,6) | 75.44 | Neutral |
| STOCHRSI(14) | 69.80 | Neutral |
| MACD(12,26) | 0.0881 | Buy |
| ADX(14) | 22.26 | Neutral |
| William %R | -32.36 | Neutral |
| CCI(14) | 112.88 | Buy |
Buy: 2
Sell: 0
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
4.491
Buy
|
4.5512
Buy
|
| MA20 |
4.253
Buy
|
4.4418
Buy
|
| MA50 |
4.3458
Buy
|
4.5569
Buy
|
| MA100 |
5.1662
Sell
|
5.3165
Sell
|
| MA200 |
7.3674
Sell
|
6.4649
Sell
|
Buy: 6
Sell: 4
Neutral: 0
Summary: Buy
According to our latest analysis, AVXL could be considered a Potential Buy, with 17 technical analysis indicators signaling 8 Buy signals, 4 signaling Sell signals and 5 Neutral signals. This might be a good time to open fresh positions on AVXL, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 59.47 indicates that AVXL is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 75.44 indicates that AVXL is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 69.8 indicates that AVXL is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 22.26 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 112.88 indicates that AVXL is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.
Long-term AVXL price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Anavex Life Sciences Corporation financial reports and earnings history, Anavex Life Sciences Corporation (AVXL) stock could reach $5.1516 by 2030, $10.69 by 2040 and $16.72 by 2050. See the projected annual prices until 2050 of the Anavex Life Sciences Corporation stock below:
- Anavex Life Sciences Corporation (AVXL) is expected to reach an average price of $8.4808 in 2035, with a high prediction of $8.9508 and a low estimate of $6.5976. This indicates an $78.17% rise from the last recorded price of $4.76.
- Anavex Life Sciences Corporation (AVXL) stock is projected to chart a bullish course in 2040, with an average price target of $10.22, representing an $114.62% surge from its current level. The forecast ranges from a conservative $9.5134 to a sky-high $10.69.
- Our analysts predict Anavex Life Sciences Corporation (AVXL) to jump 177.85% by 2045, soaring from $11.58 to an average price of $13.23, potentially reaching $13.87. While $11.58 is the low estimate, the potential upside is significant.
- Anavex Life Sciences Corporation (AVXL) stock is expected to climb by 2050, reaching an average of $16.43, a $245.15% jump from its current level. However, a wide range of estimates exists, with high and low targets of $16.72 and $13.22, respectively, highlighting the market's uncertainty.
Anavex Life Sciences Corporation Stock (AVXL) Year by Year Forecast
Anavex Life Sciences Corporation Stock (AVXL) Price Forecast for 2026
The predicted value for Anavex Life Sciences Corporation (AVXL) in 2026 is set at an average of $18.65. Estimates vary from a peak of $32.15 to a trough of $5.1519, indicating an +291.81% surge from the present price of $4.76.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| April, 2026 | $13.18 | $6.1992 | $29.34 | +176.91% |
| May, 2026 | $15.53 | $11.59 | $17.03 | +226.31% |
| June, 2026 | $15.23 | $13.44 | $16.80 | +220.04% |
| July, 2026 | $11.73 | $10.66 | $15.39 | +146.34% |
| August, 2026 | $16.15 | $11.46 | $16.64 | +239.23% |
| September, 2026 | $25.72 | $17.35 | $32.15 | +440.33% |
| October, 2026 | $20.00 | $18.02 | $27.51 | +320.18% |
| November, 2026 | $20.14 | $18.22 | $21.62 | +323.17% |
| December, 2026 | $18.60 | $17.20 | $21.30 | +290.85% |
Anavex Life Sciences Corporation Stock (AVXL) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Anavex Life Sciences Corporation (AVXL) is $16.09, with a high forecast of $24.39 and a low forecast of $7.7993. This indicates an +238.10% increase from the last price of $4.76.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $18.51 | $17.35 | $19.10 | +288.79% |
| February, 2027 | $20.90 | $17.89 | $24.39 | +339.03% |
| March, 2027 | $18.80 | $16.91 | $21.96 | +294.95% |
| April, 2027 | $15.05 | $14.09 | $20.49 | +216.21% |
| May, 2027 | $11.09 | $10.59 | $14.89 | +133.05% |
| June, 2027 | $11.03 | $9.9442 | $13.94 | +131.83% |
| July, 2027 | $12.98 | $10.56 | $14.06 | +172.62% |
| August, 2027 | $10.30 | $10.28 | $13.67 | +116.35% |
| September, 2027 | $10.38 | $7.7993 | $10.50 | +118.07% |
| October, 2027 | $9.1417 | $8.0317 | $10.47 | +92.05% |
| November, 2027 | $13.45 | $9.3821 | $13.77 | +182.63% |
| December, 2027 | $12.33 | $10.32 | $14.06 | +158.93% |
Anavex Life Sciences Corporation Stock (AVXL) Price Forecast for 2028
In 2028, Anavex Life Sciences Corporation (AVXL) is projected to reach an average price of $12.03, with a high projection of $15.92 and a low estimate of $8.1311. This indicates an +152.66% rise from the last price of $4.76.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $9.8969 | $9.8669 | $12.65 | +107.92% |
| February, 2028 | $11.00 | $9.5485 | $11.34 | +131.06% |
| March, 2028 | $12.85 | $10.74 | $14.02 | +169.97% |
| April, 2028 | $12.57 | $11.65 | $15.92 | +164.12% |
| May, 2028 | $9.134 | $8.3132 | $13.91 | +91.89% |
| June, 2028 | $10.99 | $8.6944 | $12.02 | +130.79% |
| July, 2028 | $11.23 | $10.53 | $12.61 | +135.87% |
| August, 2028 | $9.6692 | $9.2242 | $11.41 | +103.13% |
| September, 2028 | $8.4807 | $8.3757 | $10.55 | +78.17% |
| October, 2028 | $9.1323 | $8.1311 | $9.3223 | +91.86% |
| November, 2028 | $9.8343 | $8.7127 | $10.42 | +106.60% |
| December, 2028 | $8.8259 | $8.5659 | $10.86 | +85.42% |
Anavex Life Sciences Corporation Stock (AVXL) Price Forecast for 2029
The 2029 price forecast for Anavex Life Sciences Corporation Stock (AVXL) is $7.5614 on average, with a high prediction of $11.16 and a low estimate of $3.9653. This represents an +58.85% increase from the previous price of $4.76.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $8.9479 | $8.3176 | $9.4367 | +87.98% |
| February, 2029 | $8.7395 | $8.2793 | $10.59 | +83.60% |
| March, 2029 | $8.2711 | $8.2511 | $9.091 | +73.76% |
| April, 2029 | $6.7526 | $6.5026 | $8.6214 | +41.86% |
| May, 2029 | $6.4446 | $5.6034 | $6.9746 | +35.39% |
| June, 2029 | $8.2762 | $6.175 | $8.3262 | +73.87% |
| July, 2029 | $10.02 | $8.2866 | $11.16 | +110.46% |
| August, 2029 | $6.6798 | $6.459 | $7.6582 | +40.33% |
| September, 2029 | $5.6314 | $5.5814 | $6.861 | +18.31% |
| October, 2029 | $5.3733 | $5.3433 | $6.2861 | +12.89% |
| November, 2029 | $4.4949 | $4.3149 | $5.9137 | -5.57% |
| December, 2029 | $4.29 | $3.9653 | $4.6253 | -9.87% |
Anavex Life Sciences Corporation Stock (AVXL) Price Forecast for 2030
Anavex Life Sciences Corporation Stock (AVXL) is expected to reach an average price of $5.4858 in 2030, with a high forecast of $7.5456 and a low forecast of $3.4261. This signifies an +15.25% surge from the last price of $4.76.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $4.244 | $4.0524 | $5.1516 | -10.84% |
| February, 2030 | $4.4371 | $4.1948 | $5.2963 | -6.78% |
| March, 2030 | $3.6353 | $3.5703 | $4.5179 | -23.63% |
| April, 2030 | $3.83 | $3.4261 | $4.1435 | -19.54% |
| May, 2030 | $4.3702 | $3.7843 | $4.8566 | -8.19% |
| June, 2030 | $3.9806 | $3.8598 | $4.5482 | -16.37% |
| July, 2030 | $3.5596 | $3.5238 | $4.183 | -25.22% |
| August, 2030 | $3.6477 | $3.4812 | $4.6762 | -23.37% |
| September, 2030 | $4.2209 | $3.5785 | $4.2909 | -11.33% |
| October, 2030 | $6.2249 | $3.9933 | $6.6149 | +30.77% |
| November, 2030 | $3.893 | $3.788 | $7.5456 | -18.21% |
| December, 2030 | $3.8412 | $3.4488 | $4.7004 | -19.30% |
3.69%
0.68%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):